Effects of Ritalin on Postural Stability of Hyper Active Children
Information source: Soroka University Medical Center
Information obtained from ClinicalTrials.gov on November 03, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Attention Deficit Disorder With Hyperactivity
Intervention: Ritalin (Drug)
Phase: N/A
Status: Recruiting
Sponsored by: Soroka University Medical Center Official(s) and/or principal investigator(s):
Itshak Melzer, Dr, Principal Investigator, Affiliation: Ben-gurion University of the Negev, Beer-Sheva, Israel
Zmir Shorer, Dr, Study Chair, Affiliation: Soroka Medical Centar
Press Yossi, Prof, Study Director, Affiliation: Soroka Medical Center
Overall contact:
Itsahk Melzer, Dr, Phone: 972-8-6477727, Email: itzikm@bgu.ac.il
Summary
Experimental design overview The proposed project is a prospective experimental study design.
Children (age <15) suffer from attention deficit hyperactivity disorder (ADHD) that their
Parents willing to participate in the study will be tested with well-established measuring
techniques of Balance control before and 1 hour after taking of Methylphenidate (Ritalin) in
the movement and Rehabilitation Laboratory at BGU. An automated algorithm will be used to
extract standardized stabilogram-diffusion parameters from each of the COP data sets
collected during quiet standing. These parameters include diffusion coefficients, critical
displacement, critical time and scaling exponents for both lateral and anterior-posterior
sway directions (Collins & De Luca, 1993). For each of the conditions (before and 1 hour
after the use of Ritalin) in three task conditions single task; dual task (concentrating and
identifying specific music); and just Listening to a relaxing music. Participants will be
required to stand on the platform 10 times for 30 s. For each trial, they will be instructed
to sway as little as possible.
Clinical Details
Official title: Effects of Methylphenidate on Postural Stability of Children Suffer From Attention Deficit Hyperactivity Disorder (ADHD) Under Single and Dual Task Conditions.
Study design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator), Placebo Control, Parallel Assignment, Efficacy Study
Primary outcome: Postural sway measures
Eligibility
Minimum age: 6 Years.
Maximum age: 12 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Age 6-12 years old
- Diagnosed as ADHD childrens by a neurologist
- Taking methylphenidate (Ritalin)
Exclusion Criteria:
- Children who suffer from CP, or other neurological disease
- Children who suffer from psychiatric state
- Children who suffer from orthopedic condition (1/2 a year after a fracture in the
lower limb)
Locations and Contacts
Itsahk Melzer, Dr, Phone: 972-8-6477727, Email: itzikm@bgu.ac.il
SorokaUMC, Beer-Sheva, Israel; Recruiting
Itshak Melzer, PhD, Phone: 972-8-647727, Email: itzikm@bgu.ac.il
Additional Information
Starting date: October 2007
Ending date: June 2008
Last updated: March 11, 2008
|
